Nortech Directors Surge into 8,000‑Option Buy‑Syndicate, Betting on a 24% Stock Surge Ahead of 2027 Vesting Window
Inside Nortech’s surge: senior directors buy 8,000 options at zero cost, signaling strong upside for its high‑end medical display business and a potential $18 share peak.
3 minutes to read